Secondary fracture prevention: Drug treatment, fall prevention and nutrition requirements

P. Geusens*, W. F. Lems, S. Bours, J. P. Vd Bergh

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
52 Downloads (Pure)

Abstract

In view of the high imminent risk for subsequent fractures, evaluation as early as possible after the fracture will result in early decisions about drug treatment, fall prevention and nutritional supplements.

Drug treatment includes anti-resorptive and bone forming agents. Anti-resorptive therapy with broad spectrum fracture prevention and early anti-fracture effects are the first choice. In patients with multiple or severe VFs, the bone forming agent teriparatide should be considered.

Adequate calcium and vitamin D are needed in all patients, together with appropriate nutrition, including adequate protein intake. (C) 2019 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)290-300
Number of pages11
JournalBest Practice & Research in Clinical Rheumatology
Volume33
Issue number2
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Imminent fracture risk
  • Drug treatment
  • Fall prevention
  • Nutrition
  • VITAMIN-D SUPPLEMENTATION
  • LIAISON SERVICE MODELS
  • DIETARY-PROTEIN INTAKE
  • HIP FRACTURE
  • POSTMENOPAUSAL WOMEN
  • VERTEBRAL FRACTURES
  • OSTEOPOROTIC FRACTURES
  • SUBSEQUENT FRACTURES
  • RANDOMIZED-TRIAL
  • ZOLEDRONIC ACID

Cite this